Ferring will finance McGill University's Professor Bruno Tremblay
MONTREAL, April 4 /CNW Telbec/ - Underlining its commitment to the
global environment as well as challenges presented by climate change,
Ferring Pharmaceuticals, the international biopharmaceutical company,
is happy to announce a donation of $125,000 to finance research on the
condition of ice in the Arctic, under the leadership of Dr. Bruno
Tremblay, a Professor in the Department of Atmospheric and Oceanic
Sciences at McGill University.
Dr. Tremblay launches his mission today in Resolute Bay in the Arctic,
where he will install research buoys that track both ice thickness and
temperature, with the objective to better understand ice compression,
ice movement and future evolution.
We invite you to follow his mission through his blog: http://brunotremblay.tumblr.com/. Share his experience in the Great North from the comfort of your home
"We have always believed in the importance of investing in scientific
education and research, and the partnership we have developed with
McGill will make a telling contribution across a wide range of
different areas," said Michel Pettigrew (BCom '76), Ferring's President
and Chief Operating Officer.
With Ferring's engagement and financial support, Dr. Tremblay's research
models will be able to predict future ice melting in the Arctic Region.
Dr. Tremblay is internationally renowned for his expertise and has
received several Canadian and international awards and honours.
Ferring Pharmaceuticals is a Swiss-based research driven, specialty
biopharmaceutical group active in global markets. The company
identifies, develops and markets innovative products in the areas of
endocrinology, gastroenterology, gynecology, fertility and urology. In
recent years Ferring has expanded beyond its traditional European base
and has operations in over 45 countries. To learn more about Ferring or
its products please visit www.ferring.com
About McGill University
Founded in Montreal, Que., in 1821, McGill is Canada's leading
post-secondary institution. It has two campuses, 11 faculties, 10
professional schools, 300 programs of study and more than 36,000
students, including 8,300 graduate students. McGill attracts students
from over 150 countries around the world, with more than 7,200
international students making up 20 per cent of the student body.
Almost half of McGill students claim a first language other than
English, including more than 6,200 francophones. For more information: www.mcgill.ca
SOURCE FERRING PHARMACEUTICALS
For further information: